Imaging atherosclerosis and risk of plaque rupture

Current Atherosclerosis Reports

Volumn 15, Issue 10, 2013, Pages

  Osborn, Eric A ^a   Jaffer, Farouc A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atherosclerosis; Molecular imaging; Myocardial infarction; Plaque rupture; Thrombosis

Indexed keywords

ADALIMUMAB; CANAKINUMAB; FLUORODEOXYGLUCOSE; INDOCYANINE GREEN; LOSMAPIMOD; METHOTREXATE; PITAVASTATIN; PLACEBO;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; HEART MUSCLE REVASCULARIZATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; LOW DRUG DOSE; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEAR INFRARED SPECTROSCOPY; NONOBSTRUCTIVE CORONARY ARTERY DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RISK FACTOR; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; SUDDEN CARDIAC DEATH; THROMBECTOMY; THROMBOSIS; VIRTUAL REALITY; ANIMAL; BLEEDING; COMPLICATION; INFLAMMATION; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; RUPTURE; REVIEW;

ANIMALS; ATHEROSCLEROSIS; HEMORRHAGE; HUMANS; INFLAMMATION; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; RUPTURE;

EID: 84882490089     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-013-0359-z     Document Type: Article

References (41)

1. Fleg JL, Stone GW, Fayad ZA, et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012;5(9):941-55.
2. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147-56.
3. •• Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013;61(10):1041-51. This contains an extensive postmortem histomorphometric characterization of human coronary artery plaques from sudden cardiac death subjects. These high-risk plaque findings are potential targets for in vivo plaque imaging approaches.
4. Nance Jr JW, Schlett CL, Schoepf UJ, et al. Incremental prognostic value of different components of coronary atherosclerotic plaque at cardiac CT angiography beyond coronary calcification in patients with acute chest pain. Radiology. 2012;264(3):679-90.
5. • Aldrovandi A, Cademartiri F, Arduini D, et al. Computed tomography coronary angiography in patients with acute myocardial infarction without significant coronary stenosis. Circulation. 2012;126(25):3000-7. Acute coronary syndrome patients had a greater number of nonobstructive plaques in infarct-related arteries with high-risk features (fibrofatty or mixed fibrous/calcified composition) as determined by MDCTA.
6. van den Bouwhuijsen QJ, Vernooij MW, Hofman A, et al. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J. 2012;33(2):221-9.
7. Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging. 2012;5(4):397-405.
8. Lindsay AC, Biasiolli L, Lee JM, et al. Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging. 2012;5(4):388-96.
9. Sun J, Underhill HR, Hippe DS, et al. Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. JACC Cardiovasc Imaging. 2012;5(8):798-804.
10. Turc G, Oppenheim C, Naggara O, et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol. 2012;32(2):492-9.
11. Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012;59(18):1592-7.
12. Matsuo Y, Takumi T, Mathew V, et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis. 2012;223(2):365-71.
13. Maehara A, Cristea E, Mintz GS, et al. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S1-9.
14. 2, and VH IVUS TCFAs as additive predictors of adverse outcomes.
15. McPherson JA, Maehara A, Weisz G, et al. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S76-85.
16. Sanidas EA, Mintz GS, Maehara A, et al. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S95-105.
17. Brugaletta S, Garcia-Garcia HM, Serruys PW, et al. Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S19-27.
18. Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation. 2012;126(2):172-81.
19. Maurovich-Horvat P, Schlett CL, Alkadhi H, et al. Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology. 2012;265(2):393-401.
20. Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058-72.
21. Rathore S, Terashima M, Matsuo H, et al. Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study. Atherosclerosis. 2012;221(2):405-15.
22. Kato K, Yonetsu T, Kim SJ, et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012;5(11):1150-8.
23. Hattori K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging. 2012;5(2):169-77.
24. Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5(4):433-40.
25. • Prati F, Uemura S, Souteyrand G, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6(3):283-7. Thirty-one ST-elevation MI patients with nonobstructive culprit CAD following aspiration thrombectomy and OCT-defined plaque erosion (intact culprit lesion fibrous cap) were treated with percutaneous coronary stenting or dual-antiplatelet therapy alone. After more than 2 years' follow-up, no death or recurrent MI was observed in either group.
26. Patel D, Hamamdzic D, Llano R, et al. Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol. 2013;33(2):347-53.
27. Buxton DB, Antman M, Danthi N, et al. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 2011;123(19):2157-63.
28. Kerwin W, Alessio A, Ferguson M, et al. High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy. Circ Cardiovasc Imaging. 2012;5(5):683-4.
29. Bucerius J, Mani V, Moncrieff C, et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59(23):2080-8.
30. Myers KS, Rudd JH, Hailman EP, et al. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging. 2012;5(1):38-45.
31. •• Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71(5):709-18. In 60 patients with recent TIA or stroke, elevated FDG PET signal in the ipsilateral culprit carotid artery was the only independent predictor of early recurrent cerebrovascular ischemia within 90 days of the index event.
32. Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5(1):69-77.
33. Cheng VY, Slomka PJ, Le Meunier L, et al. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med. 2012;53(4):575-83.
34. Elkhawad M, Rudd JH, Sarov-Blat L, et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging. 2012;5(9):911-22.
35. Bissonnette R, Tardif JC, Harel F, et al. Effects of the tumor necrosis factor-alpha antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging. 2013;6(1):83-90.
36. • Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539-48. NaF molecular imaging identifies sites of active coronary calcification noninvasively by PET and may be a new therapeutic target. The NaF signal was elevated in proportion to coronary CT calcium scores in 119 subjects, except in those with the highest calcium scores that may represent end-stage calcified plaques.
37. Gaemperli O, Shalhoub J, Owen DR, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012;33(15):1902-10.
38. Opalinska M, Stompor T, Pach D, et al. Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. Eur J Nucl Med Mol Imaging. 2012;39(4):673-82.
39. Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol. 2011;57(25):2516-26.
40. Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17(12):1680-4.
41. • Vinegoni C, Botnaru I, Aikawa E, et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011;3(84):84ra45. The FDA-approved NIRF imaging agent ICG was demonstrated to localize within lipid-rich atherosclerotic lesions. ICG molecular imaging of atheroma with new specialized intravascular catheters may allow detailed in vivo characterization of high-risk plaques.